Lipopolysaccharide-Induced Lysosomal Cell Death Through Reactive Oxygen Species in Rat Liver Cell Clone 9

Environ Toxicol. 2024 Nov;39(11):5008-5018. doi: 10.1002/tox.24377. Epub 2024 Jul 19.

Abstract

In sepsis, bacterial components, particularly lipopolysaccharide (LPS), trigger organ injuries such as liver dysfunction. Although sepsis induces hepatocyte damage, the mechanisms underlying sepsis-related hepatic failure remain unclear. In this study, we demonstrated that the LPS-treated rat hepatocyte cell line Clone 9 not only induced reactive oxygen species (ROS) generation and apoptosis but also increased the expression of the autophagy marker proteins LC3-II and p62, and decreased the expression of intact Lamp2A, a lysosomal membrane protein. Additionally, LPS increased lysosomal membrane permeability and galectin-3 puncta formation, and promoted lysosomal alkalization in Clone 9 cells. Pharmacological inhibition of caspase-8 and cathepsin D (CTSD) suppressed the activation of caspase-3 and rescued the viability of LPS-treated Clone 9 cells. Furthermore, LPS induced CTSD release associated with lysosomal leakage and contributed to caspase-8 activation. Pretreatment with the antioxidant N-acetylcysteine (NAC) not only diminished ROS generation and increased the cell survival rate, but also decreased the expression of activated caspase-8 and caspase-3 and increased the protein level of Lamp2A in LPS-treated Clone 9 cells. These results demonstrate that LPS-induced ROS causes lysosomal membrane permeabilization and lysosomal cell death, which may play a crucial role in hepatic failure in sepsis. Our results may facilitate the development of new strategies for sepsis management.

Keywords: autophagy; hepatocyte; lipopolysaccharide; lysosomal membrane permeabilization; reactive oxygen species.

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Caspase 3 / metabolism
  • Caspase 8 / metabolism
  • Cathepsin D / metabolism
  • Cell Death / drug effects
  • Cell Line
  • Cell Survival / drug effects
  • Hepatocytes* / drug effects
  • Hepatocytes* / metabolism
  • Lipopolysaccharides* / pharmacology
  • Lipopolysaccharides* / toxicity
  • Lysosomal-Associated Membrane Protein 2 / metabolism
  • Lysosomes* / drug effects
  • Lysosomes* / metabolism
  • Rats
  • Reactive Oxygen Species* / metabolism

Substances

  • Lipopolysaccharides
  • Reactive Oxygen Species
  • Cathepsin D
  • Caspase 3
  • Caspase 8
  • Lysosomal-Associated Membrane Protein 2